[EN] BICYCLIC HETEROARYL COMPOUNDS AS INHIBITORS OF THE INTERACTION BETWEEN THE INTEGRIN ALPHA4BETA1 RECEPTOR AND VCAM-1 AND/OR FIBRONECTIN<br/>[FR] COMPOSES HETEROARYLES BICYCLIQUES UTILISES COMME INHIBITEURS DE L'INTERACTION ENTRE LE RECEPTEUR ALPHA4BETA1 DE L'INTEGRINE ET VCAM-1 ET/OU LA FIBRONECTINE
申请人:ASTRAZENECA AB
公开号:WO2001053295A1
公开(公告)日:2001-07-26
A compound of formual (I) or pharmaceutically acceptable salts or derivatives thereof; wherein variables are as defined in the specification. The compounds are useful in the treatment of disease mediated by the interaction between VCAM-1 and/or fibronectin and the integrin receptor α4β1. Pharmaceutical compositions and methods of use or treatment are also described and claimed.